Are Transplant Recipients Human Subjects When Research Is Conducted on Organ Donors?

Insights

Research on deceased organ donors can expand organ supply. Applying human subject regulations to transplant recipients is often unnecessary, suggesting a clinical consent model is more appropriate for donor intervention research.

Area of Science:

  • Transplantation research
  • Organ donation ethics
  • Human subjects research policy

Background:

  • Interventional research on deceased organ donors offers potential to increase organ availability and improve transplant success rates.
  • A significant challenge is the assumption that organ recipients are human subjects of the donor research, necessitating institutional review board oversight and research-level informed consent.
  • This assumption complicates the organ donation and transplantation process in the United States.

Purpose of the Study:

  • To critically evaluate the application of human subject regulations to deceased organ donor intervention research.
  • To propose an alternative consent model that balances innovation, transparency, and patient protection.

Main Methods:

  • Analysis of current human subject regulations and their applicability to organ donor research.
  • Examination of the ethical and practical implications of applying research-level consent to transplant recipients.
  • Proposal of a revised consent framework for deceased organ donor intervention studies.

Main Results:

  • The assumption that all organ recipients are human subjects in donor intervention research is often inaccurate.
  • Current regulations may create unnecessary burdens on research and the transplantation process.
  • A clinical consent model may be more suitable when recipients do not meet the definition of a human subject.

Conclusions:

  • Deceased organ donor intervention research requires careful consideration of regulatory application.
  • When transplant recipients are not human subjects, a clinical consent model is ethically and legally preferable.
  • This approach better supports clinical innovation while ensuring patient protection and transparency.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
566
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
527
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.8K